Physician

Priyesh Mehta, D.O.

According to 2025 Medicare claims, Priyesh Mehta, D.O. (NPI: 1811284326) practices physical medicine and rehabilitation in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is SURESH GUPTA MD INC (NPI: 1508895640; TIN: 311433944) and primary practice location at 45432-1400.

Mehta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 489 traditional Medicare patients, billed 3,023 HCPCS/CPT codes, and received $373,489 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 2,121 prescription claims across 389 beneficiaries totaling $136,613 in drug costs, led by Oxycontin (Oxycodone Hcl). Open Payments data shows 144 records totaling $418,976. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $92,227 to $373,489. In contrast, Part D prescription costs have moved from a higher plateau to a lower plateau, from $112,449 to $136,613. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	269	1,710	$92,227
2017	397	3,891	$210,993
2018	473	2,355	$235,001
2019	335	1,776	$170,594
2020	352	1,423	$138,710
2021	275	1,128	$122,902
2022	289	1,265	$135,170
2023	343	1,614	$183,721
2024	489	3,023	$373,489

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	272	1,485	$112,449
2017	377	2,616	$223,640
2018	470	2,501	$237,997
2019	394	1,359	$111,516
2020	568	1,814	$116,457
2021	328	1,059	$60,244
2022	322	1,146	$59,266
2023	351	1,718	$85,681
2024	389	2,121	$136,613

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	417	875	$189
93970	Ultrasound study of arm or leg veins with compression and maneuvers	74	118	$126
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	63	63	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	118	292	$85
80307	Testing for presence of drug, by chemistry analyzers	419	889	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	34	965	$23,919
Ubrelvy	Ubrogepant	11	294	$15,245
Hysingla Er	Hydrocodone Bitartrate	16	480	$14,198
Xtampza Er	Oxycodone Myristate	19	547	$14,140
Belbuca	Buprenorphine Hcl	14	388	$7,806

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	97	$2,379	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	47	$416,597	VERTEX PHARMACEUTICALS INCORPORATED
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Priyesh Mehta, D.O.?

Tedicare shows public-source Medicare data for Priyesh Mehta, D.O. (NPI 1811284326), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Priyesh Mehta, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Priyesh Mehta, D.O.?

Priyesh Mehta, D.O. is linked to SURESH GUPTA MD INC (billing NPI 1508895640) in the available physician profile data.

Does Priyesh Mehta, D.O. have Open Payments data?

Priyesh Mehta, D.O. has 144 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.